Literature DB >> 2168845

Luteotropic effects of prostaglandins I2 and D2 on isolated human corpora luteum.

B Bennegård1, M Hahlin, L Hamberger.   

Abstract

Human corpora lutea (CL) of the menstrual cycle or early pregnancy were excised at operation, cut into pieces, and incubated in the presence of human chorionic gonadotropin or prostaglandin (PG) I2 and D2. After incubation, the tissue levels of 3',5' cyclic adenosine monophosphate (cAMP) and the medium concentration of progesterone (P) was determined. Prostaglandin I2 and PGD2 stimulated cAMP production in the CL of both the menstrual cycle and early pregnancy. This stimulatory effect was maximal for PGI2 after 5 minutes and for PGD2 after 10 minutes. Repeated addition of the PGs during 120 minutes in the CL from the menstrual cycle resulted in a persistent cAMP elevation and stimulated P formation. The stimulatory effects of PGI2 and PGD2 on cAMP and P production in vitro indicate that these local hormones play a role in the normal development of human menstrual CL and in the persistence of the CL of early pregnancy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168845

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  3 in total

Review 1.  The human luteal paracrine system: current concepts.

Authors:  C Nappi; A R Gargiulo; C Di Carlo
Journal:  J Endocrinol Invest       Date:  1994-11       Impact factor: 4.256

2.  RUNX2 transcription factor regulates gene expression in luteinizing granulosa cells of rat ovaries.

Authors:  Eun-Sil Park; Anna-Karin Lind; Pernilla Dahm-Kähler; Mats Brännström; Martha Z Carletti; Lane K Christenson; Thomas E Curry; Misung Jo
Journal:  Mol Endocrinol       Date:  2010-03-02

3.  Hematopoietic-Prostaglandin D2 synthase through PGD2 production is involved in the adult ovarian physiology.

Authors:  Andalib Farhat; Pascal Philibert; Charles Sultan; Francis Poulat; Brigitte Boizet-Bonhoure
Journal:  J Ovarian Res       Date:  2011-02-25       Impact factor: 4.234

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.